Antibiotic-induced gut microbiome dysbiosis: risks and strategies for mitigation
Katharina Müller, Justine Gillard, Athanasios Typas, Michael Knopp, Camille V Goemans · 2026
Read Antibiotic-induced gut microbiome dysbiosis: risks and strategies for mitigation by Katharina Müller, Justine Gillard, Athanasios Typas, Michael Knopp, Camille V Goemans (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13226659.txt.
Description
Antibiotics cure infections, but they also kill helpful gut bacteria, and that collateral damage can harm health. Katharina Müller and co-authors reviewed that problem in 2026. The review explains how these drugs unbalance the gut microbiome, a state called dysbiosis, and why the gut then becomes a storehouse for resistance genes.
Those genes can move into harmful bacteria and make infections hard to treat. The authors describe how the imbalance can be studied in the lab and discuss ways to limit the damage. Options include narrower drug choices and methods that protect or restore the gut community during treatment.
Catalog record
| CREATOR | Katharina Müller, Justine Gillard, Athanasios Typas, Michael Knopp, Camille V Goemans |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |